GOG-3091- Nykode VB-C-04: A Two-Arm Randomized, Double-Blind, Placebo- Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive, PD-L1-positive, Recurrent or Metastatic Cervical Cancer who are Refractory to Pembrolizumab with Chemotherapy with/without Bevacizumab

Is this Study for You?

Let's Get Started!




University of Colorado Hospital

Principal Investigator
Photograph of Jill Alldredge

Jill Alldredge

Study ID

Protocol Number: 23-2421

More information available at ClinicalTrials.gov: NCT06099418

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers